Literature DB >> 3281095

Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.

J Yokota1, T Yamamoto, N Miyajima, K Toyoshima, N Nomura, H Sakamoto, T Yoshida, M Terada, T Sugimura.   

Abstract

We analyzed for alterations of the c-erbB-2 oncogene in 35 human stomach cancers and 8 cell lines derived from human stomach cancer. Amplification of c-erbB-2 was found in approximately 40% (5/13) of the tubular adenocarcinomas of the stomach examined, including 4 of 10 fresh tumors and one of 3 cell lines, but not in other histological types of stomach cancer examined (0/30), including 25 fresh tumors and 5 cell lines. This result strongly suggests that amplification of c-erbB-2 occurs frequently in tubular carcinomas in stomach cancer. Rearrangement of c-erbB-2 was also detected in one tubular adenocarcinoma. The rearranged fragment carried the 3' half, but not the 5' sequence, of the c-erbB-2 gene. Furthermore, one of the cellular homologues of v-erbA was amplified in 3 of 4 fresh tumors carrying the amplified c-erbB-2 gene. Both c-erbB-2 and the v-erbA homologue were expressed in all the stomach cancer cell lines tested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281095

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  71 in total

Review 1.  Gastric carcinogenesis: diet as a causative factor.

Authors:  T Sugimura; K Wakabayashi
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

2.  c-erbB-2 oncogene product expression and prognosis in gastric carcinoma.

Authors:  D A Hilton; K P West
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

3.  Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus.

Authors:  J Jankowski; G Coghill; D Hopwood; K G Wormsley
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 4.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

Review 5.  HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.

Authors:  Kazi M Ahmed; Ning Cao; Jian Jian Li
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

6.  Study of differential polymerase chain reaction of C-erbB-2 oncogene amplification in gastric cancer.

Authors:  Feng Ji; Qing-Bi Peng; Jing-Biao Zhan; You-Ming Li
Journal:  World J Gastroenterol       Date:  1999-04       Impact factor: 5.742

7.  Amplification and overexpression of the c-erbB-2 protooncogene in human gastric cancer.

Authors:  K Sasaki; Y Tomita; M Azuma; S Shida; B Simizu
Journal:  Gastroenterol Jpn       Date:  1992-04

8.  Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.

Authors:  G D Lewis; I Figari; B Fendly; W L Wong; P Carter; C Gorman; H M Shepard
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

9.  erbB-2/Her-2 gene amplification and overexpression in parotid gland tumors.

Authors:  W J Issing; A Dreps; W J Heppt; T P Wustrow; A Riederer; J F Zagury
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

10.  Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.

Authors:  J Jaehne; C Urmacher; H T Thaler; H Friedlander-Klar; C Cordon-Cardo; H J Meyer
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.